Azotobacter vinelandii DJ71, which contains a mutation in the nifV gene, was derepressed for nitrogenase in the presence of homocitrate. When dinitrogenase was isolated from this culture, it was found to be identical to the wild-type dinitrogenase. However, when the same NifV-strain was derepressed in the presence of erythrofluorohomocitrate, a homocitrate analog which produces a nitrogenase with wild-type properties in vitro, the isolated dinitrogenase was characteristic of the NifV-enzyme. These data show that homocitrate, but not fluorohomocitrate, is utilized by NifV-mutant cells. Fluorohomocitrate does not inhibit the uptake of homocitrate because the wild-type phenotype resulted when both compounds were added to the medium during nitrogenase derepression. Homocitrate lactone failed to cure the NifV-phenotype.
Biological systems utilize nitrogenase to catalyze the ATP-and reductant-dependent reduction of N2 to ammonium. Nitrogenase consists of two proteins: dinitrogenase (MoFe protein, or component I) and dinitrogenase reductase (Fe protein, or component II) (1, 4) . Dinitrogenase reductase transfers electrons one at a time to dinitrogenase, with the concomitant hydrolysis of ATP. Electrons passed to dinitrogenase are channelled to the iron-molybdenum cofactor (FeMo-co), which is the ultimate site of substrate reduction.
Analysis of mutants of Klebsiella pneumoniae defective in nitrogen fixation (ni] ) has shown that at least six gene products (nifQ, nijB, nifN, nifE, nifH, and nifV) are involved in the synthesis of active FeMo-co. The nifQ gene product is apparently required for early steps in the processing of Mo for FeMo-co synthesis (13) . Strains with mutations in nifB, nifN, and nifE produce an apo-dinitrogenase that can be activated in vitro with purified FeMo-co (19, 21) . Certain strains of K. pneumoniae and Azotobacter vinelandii with mutations in nipI (the structural gene for dinitrogenase reductase) also fail to synthesize FeMo-co (3, 20) . NifVmutants synthesize a modified form of FeMo-co (5, 18) with altered substrate reduction and inhibitor susceptibility properties. Dinitrogenase isolated from NifV-mutants effectively reduces acetylene and protons but reduces N2 poorly, and CO inhibits proton reduction (17, 18 ).
An in vitro system for the synthesis of FeMo-co has been described that requires molybdate, at least nifB, nifN, and nifE gene products (25) , dinitrogenase reductase (12, 20, 24) , and (R)-2-hydroxy-1,2,4-butanetricarboxylic acid (homocitrate) (9) . Homocitrate has been shown to be an integral part of the FeMo-co of dinitrogenase, with one mole of homocitrate being found for each mole of molybdenum (8) .
The in vitro FeMo-co synthesis system (25) allows the incorporation of homocitrate analogs (i.e., citrate, isocitrate, homoisocitrate, etc.) to produce modified forms of FeMo-co (6, 11, 16) . Dinitrogenases containing these aberrant forms of FeMo-co exhibit altered substrate specificity and inhibitor susceptibility. Use of citrate in place of homocitrate in the in vitro FeMo-co synthesis system results in the formation of * Corresponding author.
holo-dinitrogenase with effective proton and acetylene reduction activities but with poor N2 reduction and no HD formation (6) . In addition, proton reduction is inhibited by carbon monoxide (CO). These results are analogous to dinitrogenase from nifV mutants (5, 17) , and citrate was isolated from dinitrogenase of such a mutant of K. pneumoniae (15) .
Accumulation of homocitrate by K. pneumoniae is correlated to the presence of a functional nifV gene, which apparently encodes homocitrate synthase (10) . Homocitrate was found to accumulate in the medium of K. pneumoniae cultures during derepression for nitrogenase (9) . The addition of homocitrate to the medium of K. pneumoniae NifVmutants restores the wild-type phenotype (7) . Here, we report that the addition of homocitrate, but not fluorohomocitrate or homocitrate lactone, to the medium of A. vinelandii NifV-mutants cures that phenotype and results in diazotrophic growth comparable to that of wild-type cells.
MATERIALS AND METHODS
A. vinelandii UW is wild type, while DJ71 and DJ388 are NifV-deletion mutants which were generous gifts from Dennis Dean. Growth and derepression of nitrogenase in mutants of A. vinelandii were accomplished as described previously (23) .
In vitro nitrogenase assays were performed in the presence of excess dinitrogenase reductase. Acetylene and proton reduction assays (25) with or without CO (6) were conducted as described previously. N2 reduction was assayed by the 15N2 fixation method using 99% "5N2 added after preincubation (2) . Crude extracts were prepared as described previously (6, 11) . Homocitrate lactone (Sigma Chemical Co.) was converted to the free acid by adjusting the solution to pH 10 with 4 N NaOH. The solution was stored overnight at 5°C, and the pH was adjusted to 8 before use. erythro-Fluorohomocitrate was synthesized by the method of Madden et al. (16) . cFigures in parentheses are percent inhibition by CO. One hundred microliters of CO gas was injected into an assay vial containing an 8-ml gas phase.
d One milliliter of cell suspension (optical density at 600 nm = 0.23) was taken from a 500-ml culture to assay whole-cell acetylene reduction activity.
eThe mixtures contained 50 ,il of extract (approximately 1.0 mg of protein) along with 0.6 ml of an ATP-regenerating mixture which contained 5 mM sodium dithionite, 30 ,ug of dinitrogenase reductase, and 25 mM Tris buffer, pH 7.4, in a final volume of 1 ml (25) . The reaction mixtures were incubated at 30°C for 30 min.
concentration of approximately 206 mg liter-' (1 mM) during nitrogenase derepression, a 10-fold increase in whole-cell acetylene reduction activity was observed after 4 h. Onemilliliter cultures of strains UW, DJ71, and DJ71 plus homocitrate show acetylene reduction activities of 6.52, 0.63, and 6.12 nmol of ethylene formed min-1 ml-1, respectively (Table 1) . Analogous results were observed by using a second NifV-A. vinelandii strain, DJ388.
Substrate reduction properties of dinitrogenase isolated from NifV-A. vinelandii cells derepressed in the presence of homocitrate. Homocitrate was added to a 500-ml culture of DJ71 at the beginning of a 4-h derepression period, and extracts were prepared by osmotic shock methods of Shah et al. (22) . In vitro and in vivo acetylene reduction activities of dinitrogenase from the NifV-mutant derepressed in the presence of homocitrate were much greater than the activity of the mutant derepressed without homocitrate (Table 1) . Dinitrogenase isolated from derepressed NifV-cells showed poor N2 reduction activity and high (52%) CO inhibition of proton reduction, whereas high N2 reduction activity and no CO inhibition of proton reduction were observed from dinitrogenase of NifV-cells derepressed in the presence of homocitrate.
Uptake hydrogenase of A. vinelandii remains membrane bound and is removed with the pellet during preparation of the crude extracts by osmotic shock (14) . Hence, proton reduction assays can be performed with osmotic shock extracts without hydrogenase interference.
Homocitrate Madden et al. (16) showed that dinitrogenase activated with FeMo-co synthesized in vitro by using erythrofluorohomocitrate effectively reduces protons (without CO inhibition), cyanide, acetylene, and N2 in a manner similar to that of homocitrate-activated dinitrogenase. However, erythro-fluorohomocitrate was unable to cure the NifVphenotype in vivo. Poor whole-cell acetylene reduction was observed when e,ythro-fluorohomocitrate was added to the medium during nitrogenase derepression of NifV-cells at concentrations as high as 1.0 mM. In vitro substrate reduction properties of dinitrogenase isolated from NifV-cells derepressed with erythro-fluorohomocitrate were characteristic of the NifV-nitrogenase (i.e., high CO inhibition [48%] of proton reduction and poor N2 reduction) ( (Fig. 1) . Low levels of growth and nitrogenase activity were observed when NifV-cultures were grown in homocitrate-free medium.
The response of NifV-cells to homocitrate was investigated by adding homocitrate (1 mM) at the time ammonium acetate-grown cells were placed in nitrogen-free medium (Fig. 1) . Differences in cell growth and nitrogenase activity due to added homocitrate were evident within 2 to 4 h. It is interesting that NifV-cells derepressed for nitrogenase in the presence of a lower concentration of homocitrate (0.2 mM) required more than 6 h to reveal dramatic differences in whole-cell acetylene reduction activity (data not shown). When homocitrate (1 mM) was added at 5 h after starting nitrogenase derepression, the subsequent response to homocitrate (i.e., whole-cell acetylene reduction activity and cell growth) was comparable to that of cultures initially derepressed in the presence of homocitrate (Fig. 1) . FeMo-co synthesis and subsequent activation of apo-dinitrogenase in vitro require less than 30 min (25) . Taken together, these results suggest that the uptake of homocitrate by NifV-cells and its accumulation to optimal levels within cells are limiting factors in the ability of the added homocitrate to cure the NifV-phenotype.
These data provide additional in vivo and in vitro evidence that the lack of homocitrate is responsible for the NifVphenotype. Furthermore, homocitrate can be taken up by NifV-A. vinelandii cells, curing the NifV-phenotype, and can result in accelerated diazotrophic growth. vinelandii NifV-cells to homocitrate. Cell growth and whole-cell acetylene reduction activity of strain DJ71 (L), strain DJ71 plus homocitrate (H), strain DJ71 plus homocitrate added 5 h after nitrogenase derepression (0), and wild-type cells in nitrogen-free medium (0). One-milliliter culture samples were taken for growth and whole-cell acetylene reduction assays. Cell growth was determined on the basis of the increase in light scattered at 600 nm. Whole-cell acetylene reduction assays were determined by the method of Shah et al. (23) .
